Credence Research Blog
Analyst-reviewed explainers, technology comparisons and data-led insights on data center infrastructure, biopharma manufacturing and the energy transition.
Biologics vs. Biosimilars: What Manufacturers Need to Know
A biosimilar is a highly similar version of an approved biologic, not an exact copy, and its approval rests on a stepwise comparability package led by analytics. This guide explains the U.S. and EU pathways, exclusivity rules, recent FDA and EMA moves to cut clinical requirements and what they mean for manufacturing and market access.
Oct 24, 2026
Air Cooling vs. Liquid Cooling in High-Density Data Centers
Air cooling still serves most racks up to roughly 20 kW, but AI and HPC densities push operators toward rear-door, direct-to-chip and immersion liquid cooling. This guide compares the options on density, energy, water, retrofit limits, reliability and cost, and sets out a decision framework by rack density.
Oct 24, 2026
Green Hydrogen vs. Blue Hydrogen: Production and Commercial Trade-offs
Green hydrogen comes from renewable-powered electrolysis, while blue hydrogen comes from natural gas with carbon capture. This guide compares their emissions, regulatory treatment, cost drivers, water needs and best-fit end uses, and lists what buyers should verify.
Oct 24, 2026
How Biologics Are Manufactured: A Step-by-Step Overview
Biologics are made by engineered living cells, grown in bioreactors and purified through a tightly controlled sequence of steps. This guide walks through each stage, the regulatory framework behind it and what buyers should evaluate in a manufacturing partner.
Oct 24, 2026
What Is an AI Data Center? Key Components and Design Priorities
AI data centers are built around tightly coupled GPU clusters that draw more than 100 kW per rack. This guide explains the five building blocks inside them, why grid power now sets the pace of new capacity and which design priorities decide whether a facility performs.
Oct 24, 2026